Results 1 to 10 of about 58,766 (263)
Interleukin‐5‐producing malignant pleural mesothelioma with eosinophilic pleural effusion
Thoracic Cancer, 2020 Malignant tumors are often associated with eosinophilic pleural effusion. Here, we encountered a case of interleukin‐5 (IL‐5)‐producing malignant pleural mesothelioma with eosinophilic pleural effusion. The patient was a 50‐year‐old male.
Eiji Takeuchi +2 more
exaly +2 more sources
BMC Pulmonary Medicine, 2023 Aim To investigate the diagnostic value of combined detection of SHOX2 and RASSF1A gene methylation with carcinoembryonic antigen (CEA) level in diagnosing malignant pleural effusion.
Shaosen Chen +4 more
doaj +2 more sources
Life, 2023 Malignant pleural effusion is associated with a poor prognosis and, while risk stratification models exist, prior studies have not evaluated pleural fluid resolution and its association with survival.
Christina R. MacRosty +5 more
doaj +4 more sources
Egyptian Journal of Chest Disease and Tuberculosis, 2015 Introduction: Distinction between malignant and non-malignant pleural effusion is of great importance in the patient management. The aim: We examined the diagnostic value of C-reactive protein (CRP) and serum amyloid A (SAA) in distinguishing different ...
Hala Mohamed Shalaby Samaha +3 more
doaj +2 more sources
Malignant pleural effusion [PDF]
QJM, 2013 Malignant pleural effusion (MPE) refers to the presence of neoplastic cells in the pleural fluid. Approximately 40 000 people per year in the UK are affected by MPE and it is associated with significant morbidity and an overall poor prognosis. Management
Egan, A. M. +3 more
core +3 more sources
Egyptian Journal of Chest Disease and Tuberculosis, 2016 Background: Despite the fact that Light’s criteria remain the gold standard approach in differentiating exudates from transudates, several fluid markers have been introduced for establishing the cause of pleural effusion to differentiate types of pleural
Heba M. Atef +3 more
doaj +2 more sources
Evaluation of pleural fluid YKL-40 as a marker of malignant pleural effusion
Egyptian Journal of Chest Disease and Tuberculosis, 2015 The glycoprotein YKL-40 is synthesized both by cancer cells and by tumor-associated macrophages and plays a functional role in tumor progression. Consequently, high serum YKL-40 levels have been associated with a poor prognosis in patients with several ...
Adel Attia +3 more
doaj +2 more sources
Egyptian Journal of Chest Disease and TuberculosisBackground Pleural effusions can be caused by various diseases, making their diagnosis challenging. Light’s criteria are often used to distinguish transudative and exudative effusions.
Nashwa A. Amin +6 more
doaj +2 more sources
Management of malignant pleural effusion
Clinical Pulmonary Medicine, 2018 Malignant pleural effusion is a common clinical problem with an increasing incidence that may be seen to complicate the management of almost all forms of cancer.
Rahman, Najib, McCracken, DJ, Rahman, NM
core +2 more sources
Clinics in Chest Medicine, 2018 Malignant pleural effusion (MPE) refers to the presence of neoplastic cells in the pleural fluid. Approximately 40 000 people per year in the UK are affected by MPE and it is associated with significant morbidity and an overall poor prognosis. Management
Rachelle Asciak, Najib M Rahman
exaly +1 more source